Genmab A/S (LON:0MGB)
London
· Delayed Price · Currency is GBP · Price in DKK 1,315.51
+0.59 (0.04%)
At close: Jun 30, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 9.24 billion as of July 3, 2025. Its market cap has decreased by -29.60% in one year.
Market Cap
9.24B
Enterprise Value
6.78B
Revenue
2.50B
Ranking
n/a
PE Ratio
10.48
Stock Price
1,315.51
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 9.24B, an increase of 3,120.71%. That is a compound annual growth rate of 15.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.28B |
| Shell | 155.15B |
| HSBC Holdings | 153.72B |
| Unilever | 112.24B |
| Rolls-Royce Holdings | 80.35B |
| British American Tobacco p.l.c. | 77.53B |
| Rio Tinto Group | 72.88B |
| RELX PLC | 71.39B |